BG107857A - Лактамни съединения и фармацевтичното им използване - Google Patents

Лактамни съединения и фармацевтичното им използване Download PDF

Info

Publication number
BG107857A
BG107857A BG107857A BG10785703A BG107857A BG 107857 A BG107857 A BG 107857A BG 107857 A BG107857 A BG 107857A BG 10785703 A BG10785703 A BG 10785703A BG 107857 A BG107857 A BG 107857A
Authority
BG
Bulgaria
Prior art keywords
group
substituent
groups
ring
acyl
Prior art date
Application number
BG107857A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yukio Iino
Takao Ikenoue
Nobuo Kondo
Hiroyuki Matsueda
Toshihiro Hatanaka
Ryusuke Hirama
Yoko Masuzawa
Fumio Ohta
Akiyo Yamazaki
Original Assignee
Ajinomoto Co.,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co.,Inc. filed Critical Ajinomoto Co.,Inc.
Publication of BG107857A publication Critical patent/BG107857A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
BG107857A 2000-12-01 2003-05-29 Лактамни съединения и фармацевтичното им използване BG107857A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000367175 2000-12-01
PCT/JP2001/010435 WO2002044180A1 (fr) 2000-12-01 2001-11-29 Composes de lactame et leur utilisation medicale

Publications (1)

Publication Number Publication Date
BG107857A true BG107857A (bg) 2004-06-30

Family

ID=18837660

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107857A BG107857A (bg) 2000-12-01 2003-05-29 Лактамни съединения и фармацевтичното им използване

Country Status (26)

Country Link
US (3) US7153850B2 (ko)
EP (1) EP1346993B1 (ko)
JP (2) JP3826400B2 (ko)
KR (1) KR100826818B1 (ko)
CN (2) CN100577651C (ko)
AT (1) ATE446297T1 (ko)
AU (3) AU1850202A (ko)
BG (1) BG107857A (ko)
BR (1) BR0115852A (ko)
CA (1) CA2430124C (ko)
CZ (1) CZ20031520A3 (ko)
DE (1) DE60140270D1 (ko)
ES (1) ES2331299T3 (ko)
HU (1) HUP0400806A3 (ko)
IL (1) IL156158A0 (ko)
MX (1) MXPA03004876A (ko)
NO (1) NO325401B1 (ko)
NZ (1) NZ526164A (ko)
PL (1) PL362835A1 (ko)
RU (1) RU2287530C2 (ko)
SK (1) SK6582003A3 (ko)
TW (1) TWI241302B (ko)
UA (1) UA76969C2 (ko)
WO (1) WO2002044180A1 (ko)
YU (1) YU42603A (ko)
ZA (1) ZA200304100B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1346993B1 (en) * 2000-12-01 2009-10-21 Ajinomoto Co., Inc. Lactam compounds and medical use thereof
KR20050097537A (ko) * 2003-02-07 2005-10-07 아지노모토 가부시키가이샤 당뇨병 치료제
CA2544310A1 (en) 2003-10-31 2005-05-12 Ajinomoto Co., Inc. New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
CA2553329A1 (en) * 2004-01-14 2005-07-28 Ajinomoto Co., Inc. New fused polycyclic compounds
ZA200709235B (en) * 2005-04-28 2009-09-30 Ajinomoto Kk Novel lactam compound
WO2008126920A1 (ja) 2007-04-11 2008-10-23 Ajinomoto Co., Inc. 糖尿病治療薬
WO2008139574A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
WO2008139575A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. 経口投与用製剤
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
CN101619041B (zh) * 2008-07-02 2012-07-04 重庆华邦制药股份有限公司 一种二酮基含氮环化合物的合成方法及其中间体
JP2012180282A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
JP2012180283A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
RU2017126027A (ru) * 2014-12-22 2019-01-24 ЕА Фарма Ко., Лтд. Лекарственное средство для лечения расстройств эпителия роговицы
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
BR112021014509A2 (pt) * 2019-01-23 2021-09-28 Glycolysis Biomed Co., Ltd Compostos de beta-lactama ou sais dos mesmos para uso na prevenção de ação prolongada ou tratamento de um transtorno de metabolismo de glicose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US48847A (en) * 1865-07-18 Improvement in vessels for reception and transportation of night-soil
US189597A (en) * 1877-04-17 Improvement in portable wash-stands
CN1162429C (zh) 1997-07-30 2004-08-18 惠氏公司 三环后叶加压素激动剂
JP4204657B2 (ja) * 1997-12-05 2009-01-07 有限会社ケムフィズ 糖尿病の予防・治療剤
EP1346993B1 (en) * 2000-12-01 2009-10-21 Ajinomoto Co., Inc. Lactam compounds and medical use thereof
KR20050097537A (ko) 2003-02-07 2005-10-07 아지노모토 가부시키가이샤 당뇨병 치료제

Also Published As

Publication number Publication date
US7153850B2 (en) 2006-12-26
KR20030051893A (ko) 2003-06-25
NO325401B1 (no) 2008-04-21
US7632830B2 (en) 2009-12-15
US20060189597A1 (en) 2006-08-24
CN100577651C (zh) 2010-01-06
IL156158A0 (en) 2003-12-23
AU2006241377A1 (en) 2006-12-14
MXPA03004876A (es) 2004-01-27
JP2006213732A (ja) 2006-08-17
CN1911915A (zh) 2007-02-14
JP4505753B2 (ja) 2010-07-21
PL362835A1 (en) 2004-11-02
SK6582003A3 (en) 2003-09-11
NO20032439D0 (no) 2003-05-28
TWI241302B (en) 2005-10-11
KR100826818B1 (ko) 2008-05-02
ATE446297T1 (de) 2009-11-15
US7326701B2 (en) 2008-02-05
ES2331299T3 (es) 2009-12-29
CA2430124A1 (en) 2002-06-06
CA2430124C (en) 2011-01-11
EP1346993A1 (en) 2003-09-24
CZ20031520A3 (cs) 2003-10-15
WO2002044180A1 (fr) 2002-06-06
DE60140270D1 (de) 2009-12-03
JP3826400B2 (ja) 2006-09-27
US20040048847A1 (en) 2004-03-11
RU2287530C2 (ru) 2006-11-20
EP1346993A4 (en) 2005-12-21
YU42603A (sh) 2006-03-03
NZ526164A (en) 2004-09-24
CN1269818C (zh) 2006-08-16
UA76969C2 (en) 2006-10-16
AU2006241377B2 (en) 2009-01-08
AU1850202A (en) 2002-06-11
HUP0400806A3 (en) 2007-11-28
ZA200304100B (en) 2004-08-22
AU2002218502B2 (en) 2006-09-21
NO20032439L (no) 2003-07-18
JPWO2002044180A1 (ja) 2004-04-02
US20080096862A1 (en) 2008-04-24
EP1346993B1 (en) 2009-10-21
CN1487940A (zh) 2004-04-07
BR0115852A (pt) 2003-12-23
HUP0400806A2 (hu) 2004-07-28

Similar Documents

Publication Publication Date Title
US7326701B2 (en) Lactam compounds and pharmaceutical use thereof
EP1786773B1 (en) Isoindolin-1-one derivatives
KR101293935B1 (ko) 안드로겐 수용체 조절 화합물 및 방법
US20030144338A1 (en) Tyrosine phosphatase inhibitors
RU2720488C2 (ru) Замещенные амино шестичленные насыщенные гетероалициклы в качестве ингибиторов dpp-iv длительного действия
Mano et al. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase
CN109641852B (zh) 作为gpr40-和gpr120-激动剂的磺酰胺
OA12631A (fr) Amides d'acide anthranilique avec une chaîne latérale hétéroarylsulfonyle, procédé our leur préparation, leur utilisation comme médeicament ou comme agent de diagnostic et préparations pharmaceutiquescontenant lesdits composés.
EP1981842A2 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
JP2005526024A (ja) インスリン分泌を阻害するための化合物及びそれに関連する方法
CN113454077A (zh) 用于治疗hbv感染或hbv诱发的疾病的酰胺衍生物
EP1707567A1 (en) Novel fused-ring compound
US11584722B2 (en) Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
KR20040089106A (ko) 벤즈아제핀 화합물의 고체 염 및 약제학적 화합물의제조에서 이의 용도
JPH05331129A (ja) カフェー酸誘導体及びそれを含む医薬組成物
JP2022542613A (ja) ヒトａｔｇｌの阻害剤
JP3562770B2 (ja) ベンズアゼピン−２−オン誘導体
FR2932480A1 (fr) Phenyl-alkyl-piperazines ayant une activite modulatrice du tnf
JP2000191663A (ja) 縮合ピリダジン誘導体の製造法
BE843281A (fr) Nouvelles 10-(omega-(benzoylpiperidino)alkyl) phensothiazines, utiles notamment comme agents tranquillisants, et leur procede de preparation